Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    July 2021
  1. JAFFE S
    US FDA defends approval of Alzheimer's disease drug.
    Lancet. 2021;398:12.
    PubMed    


    March 2021
  2. SCHELTENS P, De Strooper B, Kivipelto M, Holstege H, et al
    Alzheimer's disease.
    Lancet. 2021 Mar 2. pii: S0140-6736(20)32205.
    PubMed     Abstract available


    February 2021
  3. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    PubMed    


    June 2020
  4. FORTEA J, Vilaplana E, Carmona-Iragui M, Benejam B, et al
    Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Lancet. 2020;395:1988-1997.
    PubMed     Abstract available


  5. HEAD E, Ances B
    Biomarkers in Down syndrome can help us understand Alzheimer's disease.
    Lancet. 2020;395:1951-1953.
    PubMed    


    February 2020
  6. SEN A, Jette N, Husain M, Sander JW, et al
    Epilepsy in older people.
    Lancet. 2020;395:735-748.
    PubMed     Abstract available


  7. WATTS G
    Giovanna Mallucci: redefining neurodegeneration.
    Lancet. 2020;395:486.
    PubMed    


    September 2019
  8. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    PubMed    


    August 2019
  9. BAKHTA K, Cecillon E, Lacombe E, Lamy M, et al
    Alzheimer's disease and neurodegenerative diseases in France.
    Lancet. 2019;394:466-467.
    PubMed    


    April 2019
  10. BARNETT R
    Alzheimer's disease.
    Lancet. 2019;393:1589.
    PubMed    


    January 2019
  11. SCHOTT JM, Aisen PS, Cummings JL, Howard RJ, et al
    Unsuccessful trials of therapies for Alzheimer's disease.
    Lancet. 2019;393:29.
    PubMed    


  12. ANDERSON RM, Hadjichrysanthou C, Evans S, McRae-McKee K, et al
    Unsuccessful trials of therapies for Alzheimer's disease - Authors' reply.
    Lancet. 2019;393:29-30.
    PubMed    


    June 2018
  13. BURKI T
    Alzheimer's disease research: the future of BACE inhibitors.
    Lancet. 2018;391:2486.
    PubMed    


    February 2018
  14. WATTS G
    Prospects for dementia research.
    Lancet. 2018;391:416.
    PubMed    


    November 2017
  15. ANDERSON RM, Hadjichrysanthou C, Evans S, Wong MM, et al
    Why do so many clinical trials of therapies for Alzheimer's disease fail?
    Lancet. 2017;390:2327-2329.
    PubMed    


    December 2016
  16. THE LANCET
    Alzheimer's disease: expedition into the unknown.
    Lancet. 2016;388:2713.
    PubMed    


    November 2016
  17. GAUTHIER S, Feldman HH, Schneider LS, Wilcock GK, et al
    Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
    Lancet. 2016 Nov 15. pii: S0140-6736(16)31275.
    PubMed     Abstract available


  18. RAFII MS
    Targeting tau protein in Alzheimer's disease.
    Lancet. 2016 Nov 15. pii: S0140-6736(16)32107.
    PubMed    


  19. SNYDER A
    Allen Roses.
    Lancet. 2016;388:2232.
    PubMed    


    August 2016
  20. SCHNEIDER LS
    Reduce vascular risk to prevent dementia?
    Lancet. 2016;388:738-40.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: